−£134k
vs Dec 2024Active13441054Private limited companyCalne
NEURONE LIMITED
Significant control: Psi Pharmaceuticals Ltd (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Neurone Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Neurone Limited sell?
Registered activity: Manufacture of pharmaceutical preparations (SIC 21200). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
NEURONE LIMITED is an active private limited company (company number 13441054) incorporated on 7 June 2021, registered in Calne. Its registered activity is manufacture of pharmaceutical preparations (SIC 21200). Latest micro accounts cover the period ending 31 December 2025, showing net assets of −£134k, with 5 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 92% on the prior period (−£70k).
Peer position · net assets
By net assets it sits in the bottom quarter of 307 comparable companies in the UK (median £1,000, upper quartile £146k).
02
Ownership and control
- Psi Pharmaceuticals Ltd
- owns 75–100% of shares
- Mr Adam David George
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 7 June 20215 yrs ago
- Next accounts due
- 30 September 2027in 337 days
- Confirmation statement due
- 21 June 2027in 236 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 21200
- Manufacture of pharmaceutical preparations
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
5
No changevs Dec 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | −£134k | — | — | £70k | — | — | 5 |
| 31 December 2024 | −£70k | — | — | £2,073 | — | — | 5 |
Current ratio3.95Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets below zeroNet assets £-134,379 at 31 December 2025
- Net assets down 25% or more on the prior period-91.5% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 3.95
- Incorporated five or more years agoIncorporated 7 June 2021
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 337 days
- Confirmation statement duein 236 days
- Accounts period endNet liabilities £134k · micro accounts
- Accounts period endNet liabilities £70k · micro accounts
- Incorporated
08
Similar companies in the UK
- COVGUARD LIMITEDCheltenham · inc. Jun 2021
- CEUTICA LIMITEDSwindon · inc. Jul 2021
- BARBARA MAWER ENTERPRISES LIMITEDPenzance · inc. Apr 2021
- BIOSIRIUS LTDPoole · inc. Aug 2021
- CY BIOPHARMA LTDCheltenham · inc. Mar 2021
- CF PHARMA UK LTDPeterborough · inc. Oct 2021
All companies incorporated on 7 June 2021 · in Jun 2021.
09
Reminders for NEURONE LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.